APA (7th ed.) Citation

DuPont, H. L., Almenoff, J. S., Jamindar, M. S., Bortey, E., & Steffen, R. (2023). Development of a new travellers’ diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy. Journal of travel medicine, 30(6), . https://doi.org/10.1093/jtm/taad043

Chicago Style (17th ed.) Citation

DuPont, Herbert L., June S. Almenoff, Mansi S. Jamindar, Enoch Bortey, and Robert Steffen. "Development of a New Travellers’ Diarrhoea Clinical Severity Classification and Its Utility in Confirming Rifamycin-SV Efficacy." Journal of Travel Medicine 30, no. 6 (2023). https://doi.org/10.1093/jtm/taad043.

MLA (9th ed.) Citation

DuPont, Herbert L., et al. "Development of a New Travellers’ Diarrhoea Clinical Severity Classification and Its Utility in Confirming Rifamycin-SV Efficacy." Journal of Travel Medicine, vol. 30, no. 6, 2023, https://doi.org/10.1093/jtm/taad043.